EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

ADVANCED TECHNIQUE 3D PRINTING IN THE PHARMACEUTICAL INDUSTRY WITH REGARDS TO CONVENTIONAL FORMULATION

Kavya*, Rahul Pal, Prachi Pandey, Himmat Singh Chawra and Ravindra Pal Singh

ABSTRACT

The whole world on the development in all other sectors as similar pharmaceutical have on broader development area. The recently pharmaceutical have great growth with using technique 3D Printing (3DP) as advance vehicle for the drug development and manufacturing. Three-dimensional printing (3DP) is a recent technology used to describe 3D products manufactured on a digital design platform and in a layer-by-layer fashion of the given medicinal materials. 3D printing technology has appeared as a major technological revolution of the recent years leading to the manufacturing and production of novel medical products and devices in pharmaceutical industry. The previously using this technology has gained position when the first commercial 3D tablet Spiratam® (levetiracetam) was approved by FDA in August 2015. The use of 3D printing technologies in drug delivery systems has expanded, due to its potential advantages over customizing drugs in individually adjusted doses. 3DP are precise deposition of medicaments and excipients, which might cause a change in perspective in drug configuration, production, and use. The dosage forms address the issues pertaining to on-demand manufacturing, feasibility, enhanced size, dosage and geometry, increased bioavailability with desired drug release profiles, and minimal toxicity or adverse drug reaction issues. It may help to address specific issues for various subgroups, including pediatric, geriatric, and chronic diseases. This review generally, focused on 3D Printing technology has described the advancements in manufacturing with regards the conventional dosage form (Tablet or capsule) and the futuristic potential for therapeutic approaches to bring in a vast array of useful applications and benefits to human being. As well as the compassion of the 3D Printing with the conventional manufacturing of the pharmaceutical products.

Keywords: 3D Printing, Recent Techniques, Conventional dosage form, CADD.

[Full Text Article] [Download Certificate]